Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
The new model a simple nasal spray, with no bruising, no pain and no clinic visit required removes that barrier entirely
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved This could start to bring down the cost of brand-name competitorshere's who may get to use it, and one major difference from the pricier kind
For those whod like a different approach to ADHD management, natural supplements may be a great alternative for improving brain functioning and overall quality of life
